Armata Pharmaceuticals, Inc.

AMEX:ARMP

Biotechnology

Healthcare
$2.98 -0.28%

-$0.02 today

Market cap
$110.83M
Beta
1.22
P/E (TTM)
-0.9
EPS (TTM)
-$7.74
52W Low $1.81High $16.34

Volume 0.07M

Average 0.07M

Income Statement

Follow revenue through to earnings.

Revenue

$4.90M

FY 2025 · Annual

-5.2% YoY

Operating Income

-$31.22M

FY 2025 · Annual

Net Income

-$173.80M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.47M5.51M4.53M5.17M4.9M
Cost of Revenue20.02M35.02M972K34.43M1.53M
Gross Profit(15.54M)(29.51M)3.56M(29.25M)3.37M
Gross Margin-347.4%-535.7%78.5%-565.4%68.8%
Research & Development20.02M35.02M33.77M34.43M23.72M
Selling, General & Admin8.28M7.44M10.68M13.18M12.41M
Operating Expenses8.28M7.44M44.45M13.18M34.6M
Depreciation & Amortization1.17M892K972K1.33M1.53M
EBITDA(21.92M)(36M)(65.45M)(6.85M)(155.68M)
EBITDA Margin-490.0%-653.5%-1445.1%-132.4%-3174.5%
Operating Income(23.82M)(36.95M)(40.89M)(42.44M)(31.22M)
Operating Margin-532.5%-670.8%-902.8%-820.2%-636.7%
Interest Income5K29K179K697K388K
Interest Expense64K29K2.63M10.74M16.59M
Other Income / Expenses667K29K(28.16M)23.52M(142.58M)
Income Before Tax(23.16M)(36.92M)(69.05M)(18.92M)(173.8M)
Pre-Tax Margin-517.5%-670.2%-1524.5%-365.6%-3544.0%
Income Tax Expense00000
Net Income(23.16M)(36.92M)(69.05M)(18.92M)(173.8M)
Net Margin-517.5%-670.2%-1524.5%-365.6%-3544.0%
EPS (Basic)(0.96)(1.08)(1.91)(0.52)(4.80)
EPS (Diluted)(0.96)(1.08)(1.91)(0.52)(4.80)
Weighted Avg Shares24.1M34.29M36.08M36.16M36.24M
Weighted Avg Shares (Diluted)24.1M34.29M36.08M36.16M36.24M

ARMP Earnings Waterfall · TTM

AMEX:ARMP · Revenue to Net Income

Key Ratios

EPS$-7.77
Gross Margin31.3%
Net Margin-3842.6%
P/E Ratio-0.8
P/S Ratio126.5

Analysis

$3.0M of revenue converted into -$282.6M of net income for the selected period. Gross margin is 31.3% and net margin is -3842.6%, showing how much revenue survives after costs and taxes. EPS is $-7.77, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportSep 23, 2026
8-KCurrent reportSep 14, 2026
10-QQuarterly reportAug 12, 2026

How much revenue does ARMP generate?

Armata Pharmaceuticals, Inc. (ARMP) reported $4.90M of revenue in fiscal 2025.

Is ARMP profitable?

Armata Pharmaceuticals, Inc. (ARMP) reported -$173.80M of net income, with a net margin of -3544.0%.